Literature DB >> 27324347

Downstream resource utilization following SPECT: Impact of age and gender.

Roman Zeltser1,2, Leanne M Tortez3, Regina S Druz4, Andrzej Kozikowski2,5, Amgad N Makaryus1,2, Martin Lesser2,6, Renee Pekmezaris2,5,6.   

Abstract

BACKGROUND: Previous studies have identified a downstream referral age and gender bias for invasive coronary anatomy evaluation after single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI). The present study evaluates if such bias still persists despite advancements in SPECT MPI and angiography. We hypothesized that women and patients ≥80 years old are less likely to undergo invasive coronary angiography after adjusting for clinical and scan variables.
METHODS: Patients (n = 3824) who referred to a nuclear cardiology laboratory at a tertiary medical center were retrospectively identified. Regression analysis tested age (<55; 55-69; 70-79; ≥80 years) and gender as predictors of diagnostic angiogram at 90 days post-SPECT after adjustment for known CAD, CAD risk equivalent, SSS, SDS, and LVEF.
RESULTS: Younger patients were more likely to undergo an angiogram as compared to octogenarians (77% more likely if <55 years old, 69% if 55-69 years old, and 52% if 70-79 years old). No effect was found for gender.
CONCLUSIONS: Older patients were less likely to be referred for angiogram as compared to their younger counterparts. Further study is needed to determine which factors guide this decision-making process in older adults and the influence of these factors on the referral bias.

Entities:  

Keywords:  Myocardial perfusion imaging: SPECT; SPECT; coronary artery disease

Mesh:

Year:  2016        PMID: 27324347     DOI: 10.1007/s12350-016-0464-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  19 in total

1.  Age and referral to coronary angiography after an abnormal treadmill thallium test.

Authors:  M S Lauer; F J Pashkow; C E Snader; S A Harvey; J D Thomas; T H Marwick
Journal:  Am Heart J       Date:  1997-02       Impact factor: 4.749

2.  Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators.

Authors:  R M Steingart; M Packer; P Hamm; M E Coglianese; B Gersh; E M Geltman; J Sollano; S Katz; L Moyé; L L Basta
Journal:  N Engl J Med       Date:  1991-07-25       Impact factor: 91.245

3.  Gender differences and temporal trends in clinical characteristics, stress test results and use of invasive procedures in patients undergoing evaluation for coronary artery disease.

Authors:  T D Miller; V L Roger; D O Hodge; M R Hopfenspirger; K R Bailey; R J Gibbons
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

4.  Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias?

Authors:  H M Krumholz; P S Douglas; M S Lauer; R C Pasternak
Journal:  Ann Intern Med       Date:  1992-05-15       Impact factor: 25.391

5.  Gender and referral for coronary angiography after treadmill thallium testing.

Authors:  M S Lauer; F J Pashkow; C E Snader; S A Harvey; J D Thomas; T H Marwick
Journal:  Am J Cardiol       Date:  1996-08-01       Impact factor: 2.778

6.  Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group.

Authors:  L J Shaw; G V Heller; M I Travin; M Lauer; T Marwick; R Hachamovitch; D S Berman; D D Miller
Journal:  J Nucl Cardiol       Date:  1999 Nov-Dec       Impact factor: 5.952

7.  Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials).

Authors:  V S DeGeare; G W Stone; L Grines; B R Brodie; D A Cox; E Garcia; T P Wharton; J A Boura; W W O'Neill; C L Grines
Journal:  Am J Cardiol       Date:  2000-07-01       Impact factor: 2.778

8.  Stress single photon emission computed tomography for detection of coronary artery disease and risk stratification of asymptomatic patients at moderate risk.

Authors:  Masud H Khandaker; Todd D Miller; Panithaya Chareonthaitawee; J Wells Askew; David O Hodge; Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2009-05-14       Impact factor: 5.952

9.  Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.

Authors:  Lee Fong Ling; Thomas H Marwick; Demetrio Roland Flores; Wael A Jaber; Richard C Brunken; Manuel D Cerqueira; Rory Hachamovitch
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-17       Impact factor: 7.792

10.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.